- £81.91bn
- £95.80bn
- £32.67bn
REG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - US FDA approves GSK’s BLENREP for multiple myeloma
AnnouncementREG - GlaxoSK Capital PLC - Publication of a Prospectus
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Sanofi/GSK to supply EU with 300m COVID 19 doses
AnnouncementREG - GlaxoSmithKline PLC - Sanofi & GSK picked for Op. Warp Speed by US Gov.
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - 2nd Quarter Results
AnnouncementREG - GlaxoSmithKline PLC - Sanofi and GSK agree UK doses of COVID-19 vaccine
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK receives positive CHMP opinion for Belamaf
AnnouncementREG - GlaxoSmithKline PLC - GSK and CureVac enter collaboration
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - FDA Panel Votes IN FAVOR of Belantamab mafodotin
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
Announcement